Biomarkers, Laboratory and Plaque - Cardiovascular Update

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

We investigated whether treatment with LDE-paclitaxel changes plaque progression by coronary CT angiography and is safe in patients with chronic coronary artery disease. Clinical and laboratory safety evaluations were made at baseline and every 3 weeks until the end of the study.

Coronary Artery Disease

Coronary Artery Disease Laboratory Plaque Biomarkers

Coronary Artery Calcification: Current Concepts and Clinical Implications

Circulation

JANUARY 15, 2024

Nevertheless, the relationship between CAC and the susceptibility of a plaque to provoke a thrombotic event remains incompletely understood. This review summarizes the current understanding and literature on CAC.

Coronary Artery Disease

Coronary Artery Disease Atherosclerosis Laboratory Plaque

Micro and Nanoplastics and Cardiovascular Events – Recent Study

All About Cardiovascular System and Disorders

MARCH 7, 2024

Detailed analysis of the excised carotid plaques were carried out with pyrolysis-gas chromatography-mass spectrometry, stable isotope analysis, and electron microscopy. Inflammatory biomarkers were also estimated. Comparison was with those who had no evidence of these plastics in the plaques.

Plaque

Plaque Myocardial Infarction Laboratory Cardiac Function

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

Coronary Artery Calcification: Current Concepts and Clinical Implications

Micro and Nanoplastics and Cardiovascular Events – Recent Study

Stay Connected